Rick Wise
Stock Analyst at Stifel
(4.14)
# 458
Out of 5,126 analysts
267
Total ratings
60.83%
Success rate
9.85%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $98 | $80.65 | +21.51% | 4 | Feb 5, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $125 → $110 | $76.27 | +44.22% | 18 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $205 → $220 | $239.99 | -8.33% | 8 | Jan 22, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $105 → $110 | $78.71 | +39.75% | 29 | Jan 20, 2026 | |
| MDLN Medline | Initiates: Buy | $46 | $47.30 | -2.75% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $2.26 | +32.74% | 10 | Jan 7, 2026 | |
| SOLV Solventum | Maintains: Buy | $88 → $105 | $78.12 | +34.41% | 2 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $4.50 | +77.78% | 6 | Jan 7, 2026 | |
| LIVN LivaNova | Maintains: Buy | $65 → $70 | $66.56 | +5.17% | 7 | Jan 7, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $210 → $215 | $210.02 | +2.37% | 9 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $27.74 | +44.20% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $16.65 | +20.12% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $102.90 | +2.04% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $39.59 | +16.19% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $118 | $89.91 | +31.24% | 16 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $21.73 | +15.05% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.50 | +233.33% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $41.52 | +32.47% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $110.83 | +30.83% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $25.51 | +9.76% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $37.11 | +29.35% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $358.29 | +22.81% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $488.15 | +24.96% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $139.15 | +36.54% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $6.45 | +86.05% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $87.42 | -14.21% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $19.17 | +25.20% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $14.59 | +71.35% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $54.88 | +104.08% | 5 | Oct 2, 2020 |
GE HealthCare Technologies
Feb 5, 2026
Maintains: Buy
Price Target: $95 → $98
Current: $80.65
Upside: +21.51%
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $125 → $110
Current: $76.27
Upside: +44.22%
Johnson & Johnson
Jan 22, 2026
Maintains: Hold
Price Target: $205 → $220
Current: $239.99
Upside: -8.33%
Edwards Lifesciences
Jan 20, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $78.71
Upside: +39.75%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $47.30
Upside: -2.75%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $2.26
Upside: +32.74%
Solventum
Jan 7, 2026
Maintains: Buy
Price Target: $88 → $105
Current: $78.12
Upside: +34.41%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $4.50
Upside: +77.78%
LivaNova
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $66.56
Upside: +5.17%
Becton, Dickinson and Company
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $210.02
Upside: +2.37%
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $27.74
Upside: +44.20%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $16.65
Upside: +20.12%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $102.90
Upside: +2.04%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $39.59
Upside: +16.19%
Sep 19, 2025
Maintains: Buy
Price Target: $115 → $118
Current: $89.91
Upside: +31.24%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $21.73
Upside: +15.05%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.50
Upside: +233.33%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $41.52
Upside: +32.47%
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $110.83
Upside: +30.83%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $25.51
Upside: +9.76%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $37.11
Upside: +29.35%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $358.29
Upside: +22.81%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $488.15
Upside: +24.96%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $139.15
Upside: +36.54%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $6.45
Upside: +86.05%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $87.42
Upside: -14.21%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $19.17
Upside: +25.20%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $14.59
Upside: +71.35%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $54.88
Upside: +104.08%